Oireachtas Joint and Select Committees
Wednesday, 21 November 2018
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion (Resumed)
9:00 am
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
I would like to discuss the alleged delay in Ireland in getting some of these drugs onto the market. The witnesses may disagree but it has been put to me by patients, patient advocacy groups, clinicians and the pharmaceutical companies that relative to other EU countries Ireland is very slow in getting the drugs to market. For example, in the case of Translarna, 22 other countries-----